Clinical Trial Update: Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast Cancer [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the effect of zoledronic acid on bone metabolism in patients with bone metastases from prostate or breast cancer; the study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastasis
• Breast Cancer
• Prostate Cancer

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Prostate Cancer, Breast Cancer | Phase 4 | Status: COMPLETED